Physician profile
Dia Smiley
NPI 1962638437
$26,594.37
in general payments reported to CMS, 2019-2025
11 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2023: $118 · 2024: $8,255 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,950 · Travel and Lodging: $2,534 · Food and Beverage: $2,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,482.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,950.00 |
| Travel and Lodging | $2,534.40 |
| Food and Beverage | $2,519.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16,667.05 | 2024-2025 | |
| Bridgebio Pharma, INC. | $4,214.04 | 2025 | Attruby |
| Boston Scientific Corporation | $2,404.77 | 2025 | Watchman Access System, Watchman Flx, Watchman |
| Astrazeneca Pharmaceuticals LP | $2,258.29 | 2023-2025 | Wainua |
| Alnylam Pharmaceuticals INC. | $755.31 | 2024-2025 | Amvuttra, Onpattro |
| Medtronic, INC. | $139.00 | 2025 | Interstim |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.73 | 2019 | |
| Amgen INC. | $45.34 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $33.00 | 2019 | |
| Heartflow, INC. | $29.84 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dia Smiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.